Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2014 - 2017)
Amphastar Pharmaceuticals' (AMPH) quarterly Amortizatization of Intangibles came in at $7000.0 in Q2 2017, down 61.11% year-on-year from $18000.0 in Q2 2016, and down 22.22% quarter-over-quarter from $9000.0 in Q1 2017.
Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2014 - 2017) Analysis & Trends
Amphastar Pharmaceuticals' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $7000.0 for Q2 2017.
- On a quarterly basis, Amortizatization of Intangibles fell 61.11% year-over-year to $7000.0 in Q2 2017; TTM through Jun 2017 was $52000.0, a 42.22% decrease from a year earlier, with the FY2016 full-year figure at $72000.0, down 34.55% from the prior year.
- Amortizatization of Intangibles eased to $7000.0 in Q2 2017 per AMPH's latest filing, from $9000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $97000.0 in Q4 2014 and bottomed at $7000.0 in Q2 2017.
- The 4-year median for Amortizatization of Intangibles is $19000.0 (2016), against an average of $26818.2.
- Across the five-year window, Amortizatization of Intangibles tumbled 72.16% in 2015 and fell 29.63% in 2016, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $97000.0 in 2014, then tumbled by 72.16% to $27000.0 in 2015, then sank by 37.04% to $17000.0 in 2016, then slumped by 58.82% to $7000.0 in 2017.
- Per Business Quant, the three latest AMPH Amortizatization of Intangibles figures stand at $7000.0 (Q2 2017), $9000.0 (Q1 2017), and $17000.0 (Q4 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Amphastar Pharmaceuticals | 867.92 Mn | 696.78 Mn | 70.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Mar 31, 2017 | 9,000.00 |
| Mar 31, 2017 | 9,000.00 |
| Dec 31, 2016 | 17,000.00 |
| Dec 31, 2016 | 17,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Mar 31, 2016 | 18,000.00 |
| Mar 31, 2016 | 18,000.00 |
| Dec 31, 2015 | 27,000.00 |
| Dec 31, 2015 | 27,000.00 |
| Sep 30, 2015 | 27,000.00 |
| Sep 30, 2015 | 27,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Mar 31, 2015 | 28,000.00 |
| Mar 31, 2015 | 28,000.00 |